tafasitamab
incyte,morphosys
['improve ', 'dlbcl', 'tafasitamab']
congress #asco22 | of presents data from a retrospective cohort study of tafasitamab + lenalidomide vs systemic therapy in patients with r/r #dlbcl. the combination may improve os in certain patients. #medicalcongress #cancerawareness 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm